ONWARD MEDICAL BV EO -12 (63E) — Tangible Net Worth Ratio
ONWARD MEDICAL BV EO -12 (63E) has a Tangible Net Worth Ratio of 87.4% as of December 2025. This metric is calculated by deducting intangible assets (€7.00 Million) from net assets (€55.32 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 63E shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ONWARD MEDICAL BV EO -12 Tangible Net Worth Ratio (2021–2025)
This chart shows how ONWARD MEDICAL BV EO -12's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 87.4%, reflecting net assets of €55.32 Million with intangible assets of €7.00 Million EUR. For live market cap and overall valuation, see ONWARD MEDICAL BV EO -12 market capitalisation.
Annual Tangible Net Worth Ratio for ONWARD MEDICAL BV EO -12 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ONWARD MEDICAL BV EO -12 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See 63E financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.4% | €55.32 Million | €7.00 Million | €84.55 Million | ▲ +5.0 pp |
| 2024 | 82.4% | €48.05 Million | €8.46 Million | €76.14 Million | ▲ +26.8 pp |
| 2023 | 55.6% | €17.93 Million | €7.96 Million | €43.63 Million | ▼ -28.7 pp |
| 2022 | 84.3% | €52.63 Million | €8.26 Million | €76.59 Million | ▼ -5.6 pp |
| 2021 | 89.9% | €82.68 Million | €8.33 Million | €104.80 Million | — |